The whys of cancer quackery - PubMed

The whys of cancer quackery

I J Lerner. Cancer. 1984.

Abstract

The nation appears to have weathered the laetrile phenomenon. In just having passed through the greatest episode of quackery in our history, it would be appropriate to reflect on the whys of quackery: Why do some promote it? Why do so many use it? Why should the medical profession care? Using the laetrile experience as a model, the author attempts to deal with these fundamental questions, and tries in particular to sort out which factors were unique to laetrile and which factors have always been associated with quack promotions and are likely to continue. When a successful quack promotion is analyzed, a complex interplay of failures on the part of physicians and the public is observed, and the triumphs of the promoters are recognized. Finally, it is necessary to deal with the issue of the responsibility of the individual physician and of the profession in general in coping with an unsound, antiscientific medical therapeutic.

Similar articles

• Laetrile in historical perspective.

  Kardinal CG. Kardinal CG. Mo Med. 1980 Sep;77(9):564-9. Mo Med. 1980. PMID: 7001210 No abstract available.

• Cancer quackery--the past in the present.

  Janssen WF. Janssen WF. Semin Oncol. 1979 Dec;6(4):526-36. Semin Oncol. 1979. PMID: 394334 No abstract available.

• Laetrile: the regulatory challenge of an unproven remedy.

  Nightingale SL. Nightingale SL. Public Health Rep. 1984 Jul-Aug;99(4):333-8. Public Health Rep. 1984. PMID: 6431478 Free PMC article.

• Laetrile: the cult of cyanide. Promoting poison for profit.

  Herbert V. Herbert V. Am J Clin Nutr. 1979 May;32(5):1121-58. doi: 10.1093/ajcn/32.5.1121. Am J Clin Nutr. 1979. PMID: 219680 Review. No abstract available.

• Amygdalin, quackery or cure?

  Blaheta RA, Nelson K, Haferkamp A, Juengel E. Blaheta RA, et al. Phytomedicine. 2016 Apr 15;23(4):367-76. doi: 10.1016/j.phymed.2016.02.004. Epub 2016 Feb 17. Phytomedicine. 2016. PMID: 27002407 Review.

Cited by

• Physicians' attitudes toward patients' use of alternative cancer therapies.

  Bourgeault IL. Bourgeault IL. CMAJ. 1996 Dec 15;155(12):1679-85. CMAJ. 1996. PMID: 8976333 Free PMC article.

• The rise of people power.

  Chafe R, Born KB, Slutsky AS, Laupacis A. Chafe R, et al. Nature. 2011 Apr 28;472(7344):410-1. doi: 10.1038/472410a. Nature. 2011. PMID: 21525907 No abstract available.

• Unconventional cancer remedies.

  Danielson KJ, Stewart DE, Lippert GP. Danielson KJ, et al. CMAJ. 1988 Jun 1;138(11):1005-11. CMAJ. 1988. PMID: 3285984 Free PMC article. Review.

• Compassionate use of experimental therapies: who should decide?

  Zettler PJ. Zettler PJ. EMBO Mol Med. 2015 Oct;7(10):1248-50. doi: 10.15252/emmm.201505262. EMBO Mol Med. 2015. PMID: 26202382 Free PMC article.

• The association between mental distress and the use of alternative medicine among cancer patients in North Norway.

  Risberg T, Jacobsen BK. Risberg T, et al. Qual Life Res. 2003 Aug;12(5):539-44. doi: 10.1023/a:1025063705413. Qual Life Res. 2003. PMID: 13677498

Publication types

MeSH terms

Substances